Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 4Phase 2/3 2Phase NA 1Phase 1 1

Status

Recruiting 2Unknown 1Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Esophageal Neoplasms 8Esophageal Squamous Cell Carcinoma 4Clinical Stage I Esophageal Adenocarcinoma AJCC v8 1Carcinoma, Squamous Cell 1

Interventions

Cisplatin 21Radiotherapy 16Fluorouracil 16Paclitaxel 15Irinotecan 8Docetaxel 8Neoadjuvant Therapy 6Drug Therapy 5tislelizumab 4sintilimab 4Surgical Procedures, Operative 4Radiation 4Oxaliplatin 4Leucovorin 4Esophagectomy 4Capecitabine 4toripalimab 3pembrolizumab 3TP protocol 3Chemotherapy, Adjuvant 3S 1 (combination) 2Levoleucovorin 2Injections 2Cetuximab 2Carboplatin 2lenvatinib 1irinotecan sucrosofate 1durvalumab 1atropine sulfate-diphenoxylate hydrochloride drug combination 1atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Esophageal Squamous Cell Carcinoma × Esophagectomy × Clear all
NCT05357846 2026-04-30

PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)

Sun Yat-sen University

Phase 3 Recruiting
422 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT04460352 2025-03-06

NEEDS

Karolinska University Hospital

Phase 3 Recruiting
1,020 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT02465736 2024-01-16

Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)

Sun Yat-sen University

Phase 3 Unknown
610 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT01740375 2017-08-29

ESOPRESSO

Asan Medical Center

Phase 3 Terminated
486 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡